VUNO is developing AI solutions that can analyze various types of data that are generated in medical settings. The company's product lines are made to be seamlessly integrated with PACS and EMR systems or any medical devices. VUNO's portfolio includes VUNO Med-LungCT AI that detects, locates, and quantifies pulmonary lung nodules on CT images; VUNO Med-BoneAge, which is designed to assist doctors in reading a hand X-ray image to assess the bone age of a child; VUNO Med-Chest X-ray that supports physicians in the chest X-ray reading of common thoracic abnormalities on chest radiographs; VUNO Med-DeepBrain, which was developed as a diagnostic support tool for degenerative brain diseases through brain parcellation & quantification on brain MR images; VUNO Med-Fundus AI - which is a screening solution that provides findings that are essential in diagnosing of all retinal diseases; and VUNO MED-DeepASR - which is used for brain quantification to support degenerative brain diseases through brain parcellation & quantification on brain MR images. Vuno's partners include NVidia, Nuance, LG, Rayence, Sectra, Arterys, Nobori, Ferrum, M3 Inc, CHC Healthcare Group, and others.
Select investors SBI Investment, Smilegate Investment, Green Cross, Bon Angels Venture Partners, HB Investment
Last update: May 19, 2021
Disclaimer: We can not guarantee that the information on this page is 100% correct. more